Serveur d'exploration sur le peuplier - Exploration (Accueil)

Index « Keywords » - entrée « Treatment Outcome (MeSH) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Transposases (genetics) < Treatment Outcome (MeSH) < Trees (MeSH)  Facettes :

List of bibliographic references indexed by Treatment Outcome (MeSH)

Number of relevant bibliographic references: 65.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
001414 (2017) Stefan Smesny [Allemagne] ; Berko Milleit [Allemagne] ; Miriam R. Schaefer [Autriche] ; Jana Hesse [Allemagne] ; Monika Schlögelhofer [Autriche] ; Kerstin Langbein [Allemagne] ; Uta-Christina Hipler [Allemagne] ; Maximus Berger [Australie] ; David R. Cotter [Irlande (pays)] ; Heinrich Sauer [Allemagne] ; Patrick D. Mcgorry [Australie] ; G Paul Amminger [Autriche]Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.
001472 (2017) Stéphane Morandi [Suisse] ; Philippe Golay [Suisse] ; Martin Lambert [Allemagne] ; Benno G. Schimmelmann [Suisse] ; Patrick D. Mcgorry [Australie] ; Sue M. Cotton [Australie] ; Philippe Conus [Suisse]Community Treatment Order: Identifying the need for more evidence based justification of its use in first episode psychosis patients.
001499 (2017) Edwin K. Luk [Australie] ; Anastasia F. Hutchinson [Australie] ; Mark Tacey [Australie] ; Louis Irving [Australie] ; Fary Khan [Australie]COPD: Health Care Utilisation Patterns with Different Disease Management Interventions.
001629 (2016) Alexandra G. Parker [Australie] ; Sarah E. Hetrick [Australie] ; Anthony F. Jorm [Australie] ; Andrew J. Mackinnon [Australie] ; Patrick D. Mcgorry [Australie] ; Alison R. Yung [Royaume-Uni] ; Faye Scanlan [Australie] ; Jessica Stephens [Australie] ; Shelley Baird [Australie] ; Bridget Moller [Australie] ; Rosemary Purcell [Australie]The effectiveness of simple psychological and physical activity interventions for high prevalence mental health problems in young people: A factorial randomised controlled trial.
001814 (2016) Mary P. Galea [Australie] ; Fary Khan ; Bhasker Amatya ; Alaeldin Elmalik ; Marlena Klaic ; Geoff AbbottImplementation of a technology-assisted programme to intensify upper limb rehabilitation in neurologically impaired participants: A prospective study.
001886 (2016) Robert H. Six [États-Unis] ; Thomas Geurden [Belgique] ; Raj Packianathan [Australie] ; Sally Colgan [Australie] ; William R. Everett [États-Unis] ; Sarah Grace [Irlande (pays)] ; Andrew Hodge [Australie] ; Sean P. Mahabir [États-Unis] ; Melanie R. Myers [États-Unis] ; Nathalie Slootmans [Belgique] ; Kylie Davis [Australie]Evaluation of the effectiveness of a novel oral formulation of sarolaner (Simparica™) for the treatment and control of fleas on dogs.
001993 (2016) M. Alvarez-Jimenez [Australie] ; B. O'Donoghue [Australie] ; A. Thompson [Royaume-Uni] ; J F Gleeson [Australie] ; S. Bendall [Australie] ; C. Gonzalez-Blanch [Espagne] ; E. Killackey [Australie] ; L. Wunderink [Pays-Bas] ; P D Mcgorry [Australie]Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
001995 (2016) Louis Fehrenbacher [États-Unis] ; Alexander Spira [États-Unis] ; Marcus Ballinger [États-Unis] ; Marcin Kowanetz [États-Unis] ; Johan Vansteenkiste [Belgique] ; Julien Mazieres [France] ; Keunchil Park [Corée du Sud] ; David Smith [États-Unis] ; Angel Artal-Cortes [Espagne] ; Conrad Lewanski [Royaume-Uni] ; Fadi Braiteh [États-Unis] ; Daniel Waterkamp [États-Unis] ; Pei He [États-Unis] ; Wei Zou [États-Unis] ; Daniel S. Chen [États-Unis] ; Jing Yi [États-Unis] ; Alan Sandler [États-Unis] ; Achim Rittmeyer [Allemagne]Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.
001A11 (2016) Fary Khan [Australie] ; Bhasker Amatya ; Alaeldin Elmalik ; Matthew Lowe ; Louisa Ng ; Isabella Reid ; Mary P. GaleaAn enriched environmental programme during inpatient neuro-rehabilitation: A randomized controlled trial.
001A21 (2016) R. Daglas [Australie] ; S M Cotton [Australie] ; K. Allott [Australie] ; M. Yücel [Australie] ; C A Macneil [Australie] ; M K Hasty [Australie] ; B. Murphy [Australie] ; C. Pantelis [Australie] ; K T Hallam [Australie] ; L P Henry [Australie] ; P. Conus [Suisse] ; A. Ratheesh [Australie] ; L. Kader [Australie] ; M Th Wong [Australie] ; P D Mcgorry [Australie] ; M. Berk [Australie]A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up study.
001B22 (2015) Fary Khan ; Bhasker Amatya ; Jurg Kesselring ; Mary GaleaTelerehabilitation for persons with multiple sclerosis.
001B58 (2015) Fary Khan [Australie] ; Bhasker Amatya ; Louisa Ng ; Mary GaleaRehabilitation outcomes in persons with spina bifida: A randomised controlled trial.
001C19 (2015) P. Conus [Australie] ; M. Berk [Australie] ; S M Cotton [Australie] ; L. Kader [Australie] ; C. Macneil [Australie] ; M K Hasty [Australie] ; K. Hallam [Australie] ; M. Lambert [Allemagne] ; B P Murphy [Australie] ; P D Mcgorry [Australie]Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: An 8-week randomised controlled trial.
001C61 (2015) Edwin K. Luk [Australie] ; Fary Khan [Australie] ; Louis Irving [Australie]Maintaining Gains Following Pulmonary Rehabilitation.
001D11 (2015) Régis Marion-Veyron [Suisse] ; Martin Lambert [Allemagne] ; Sue M. Cotton [Australie] ; Benno G. Schimmelmann [Suisse] ; Bruno Gravier [Suisse] ; Patrick D. Mcgorry [Australie] ; Philippe Conus [Australie]History of offending behavior in first episode psychosis patients: a marker of specific clinical needs and a call for early detection strategies among young offenders.
001E00 (2015) Stefan Smesny [Allemagne] ; Berko Milleit [Allemagne] ; Miriam R. Schaefer [Australie] ; Uta-Christina Hipler [Allemagne] ; Christine Milleit [Allemagne] ; Cornelia Wiegand [Allemagne] ; Jana Hesse [Allemagne] ; Claudia M. Klier [Autriche] ; Magdalena Holub [Autriche] ; Ingrid Holzer [Autriche] ; Michael Berk [Australie] ; Patrick D. Mcgorry [Australie] ; Heinrich Sauer [Allemagne] ; G Paul Amminger [Australie]Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis.
001F11 (2015) Sue Lauder [Australie] ; Andrea Chester [Australie] ; David Castle [Australie] ; Seetal Dodd [Australie] ; Emma Gliddon [Australie] ; Lesley Berk [Australie] ; James Chamberlain [Australie] ; Britt Klein [Australie] ; Monica Gilbert [Australie] ; David W. Austin ; Michael Berk [Australie]A randomized head to head trial of MoodSwings.net.au: an Internet based self-help program for bipolar disorder.
001F22 (2015) Peter R. Little [Australie] ; Vickie L. King ; Kylie R. Davis ; Sallie B. Cosgrove ; Michael R. StegemannA blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
001F72 (2014) B J Mckinnon [États-Unis] ; T. Dumon ; R. Hagen ; E. Lesinskas ; R. Mlynski ; M. Profant ; J. Spindel ; J. Van Beek-King ; M. ZernottiVibrant soundbridge in aural atresia: does severity matter?
002017 (2014) Christopher G. Davey [Australie] ; Andrew M. Chanen ; Sue M. Cotton ; Sarah E. Hetrick ; Melissa J. Kerr ; Michael Berk ; Olivia M. Dean ; Kally Yuen ; Mark Phelan ; Aswin Ratheesh ; Miriam R. Sch Fer ; G Paul Amminger ; Alexandra G. Parker ; Danijela Piskulic ; Susy Harrigan ; Andrew J. Mackinnon ; Ben J. Harrison ; Patrick D. McgorryThe addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.
002603 (2013) Fary Khan [Australie] ; Bhasker Amatya ; Jürg KesselringLongitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Treatment Outcome (MeSH)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Treatment Outcome (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    PoplarV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Treatment Outcome (MeSH)
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 12:07:19 2020. Site generation: Wed Nov 18 12:16:31 2020